DRTS stock: Allocaria Score and valuation gap
As of 26.10.2026, ALPHA TAU MEDICAL LTD (DRTS) has an Allocaria Score of 35 out of 100, which reads as “Weak”. The model’s fair-value estimate for this company is not reliable enough to show as a number.
ALPHA TAU MEDICAL LTD · Health Care · United States · small-cap company
Allocaria Score and gap to the model’s fair-value estimate
Allocaria Score
35 out of 100
Weak Ratings as of 26.10.2026
A relative score on current evidence — not a probability, a price forecast or a guarantee.
Gap to the model’s fair-value estimate
—
The model’s fair-value estimate for this company is not reliable enough to show as a number.
low-reliability estimate
A positive figure means the price is below the model’s estimate; a negative figure means it is above.
What moves the score
- Valuation vs history lowers the score
- Quality lifts the score
Why: the two parts of the score that push it furthest from neutral — + lifts it, − lowers it. Nothing is shown when no part stands out.
Health Care in Allocaria’s coverage
ALPHA TAU MEDICAL LTD ranks 407th of 482 Health Care companies in Allocaria’s coverage by Allocaria Score; the sector median is 56 out of 100.
Other Health Care companies
Questions about this page
ALPHA TAU MEDICAL LTD has an Allocaria Score of 35 out of 100 as of 26.10.2026, which reads as “Weak”. A relative score on current evidence — not a probability, a price forecast or a guarantee.
The model’s fair-value estimate for this company is not reliable enough to show as a number. A positive figure means the price is below the model’s estimate; a negative figure means it is above.
It helps a self-directed investor decide what to study further and what to set aside. A rank is not a probability and not an order.
It shows the ratings as of 26.10.2026. The page is refreshed when the ratings are, and it is withdrawn when the data is older than about six weeks.